You'll hear that pioglitazone (Actos) slows atherosclerosis

You'll hear that pioglitazone (Actos) slows atherosclerosis.

Recent evidence suggests slower progression of atherosclerosis in patients taking pioglitazone compared to glimepiride (Amaryl).

This doesn't seem to be due to pioglitazone's glucose-lowering might be due to changes in lipids or other factors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote